Research
Hormonal
Therapy lapses with GLP-1 receptor agonists may be prevented by a multi-modal approach.
Implementing a multi-modal strategy can help maintain GLP-1 therapy adherence.
StrongSupportsmedium confidence
Therapy lapses with GLP-1 receptor agonists may be prevented by utilizing a multi-modal approach including extended dosing intervals, intermediate doses, agent interchange, efficient prior authorization communication, and cautious initiation of GLP-1 recent agonists while supply cannot meet demand.
Why this rating
The case report discusses strategies to manage therapy effectively.
Source
Navigating Glucagon-Like Peptide Receptor Agonist Reinitiation Amid Access Barriers: An Adverse Drug Event Case Report
Olivia Denny et al. · Journal of Pharmacy Practice · 2024
case_studyCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →